ENOV
Enovis Corporation
Set alert
- YTD
- -25.26%
- 1 year
- -35.13%
- Open
- 22.17
- Prev close
- 22.81
- Mkt cap
- 1.15B
- Vol
- 2.52M
- Avg vol
- 1.54M
- EPS
- -19.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.83
- High
- 22.26
- Forward P/E
- 5.64
- Beta
- 1.48
- Short ratio
- 7.14
- Inst. own
- 119.13%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 20.13
- 200-d avg
- 23.09
- 1y target
- 36.08
Key statistics
- Market cap
- 1.15B
- Enterprise value
- 2.67B
- Trailing P/E
- 0.00
- Forward P/E
- 5.64
- PEG ratio
- 3.45
- Price / sales
- 0.50
- Price / book
- 0.78
- EPS (TTM)
- -19.23
- Beta
- 1.48
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -47.97%
- Revenue (TTM)
- 2.30B
- Revenue growth
- 3.20%
- Free cash flow
- 185.94M
- Total cash
- 12.56M
- Total debt
- 1.37B
- Return on equity
- -54.14%
- Shares outstanding
- 57.67M
- Short % of float
- 24.18%
- 50-day average
- 20.13
- 200-day average
- 23.09
Analyst view
Consensus: strong buy
- Target (low)
- 24.00
- Target (mean)
- 36.08
- Target (high)
- 47.00
- Strong buy2
- Buy10
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.76681.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Oct 3, 2026 | 0.767 | — | — | — |
| Aug 6, 2026 | Jul 3, 2026 | 0.847 | 0.90 | +0.05 | +6.26% |
| May 7, 2026 | Apr 3, 2026 | 0.82 | 0.89 | +0.07 | +8.54% |
| Feb 26, 2026 | Dec 31, 2025 | 0.81 | 0.95 | +0.14 | +17.28% |
| Nov 6, 2025 | Oct 3, 2025 | 0.67 | 0.75 | +0.08 | +11.94% |
| Aug 7, 2025 | Jul 4, 2025 | 0.74 | 0.79 | +0.05 | +6.76% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | Needham | main | Buy | Buy |
| Sep 2, 2026 | Wells Fargo | main | Overweight | Overweight |
| Sep 2, 2026 | Citizens | main | Market Outperform | Market Outperform |
| Sep 2, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Sep 1, 2026 | BTIG | main | Buy | Buy |
| Aug 17, 2026 | Canaccord Genuity | main | Buy | Buy |
About Enovis Corporation
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions. The Reconstructive segment develops, manufactures, markets, and distributes surgical solutions that restore mobility and improve patient outcomes, which includes a range of differentiated implants, instrumentation, and enabling technologies used in elective and non-elective joint replacement, limb reconstruction, and foot and ankle procedures; and products for the hip, knee, shoulder, elbow, extremity reconstruction and fixation, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes a range of products which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company distributes its products through independent distributors, direct salespeople, and patients. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Lewisville, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- enovis.com
News
- Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
- electroCore (NASDAQ:ECOR) and Enovis (NYSE:ENOV) Head-To-Head Comparison
- Transcript: Enovis Q2 2026 Earnings Conference Call
- Critical Survey: Enovis (NYSE:ENOV) vs. Nexalin Technology (NASDAQ:NXL)
- Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
- Enovis (NYSE:ENOV) Hits New 52-Week Low – What’s Next?
- Insider at Medical Device Maker Buys More Than 7,500 Shares
- What Makes Enovis (ENOV) a New Buy Stock
- Enovis (ENOV) Loses 33% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition
Your note
Sign in to keep a note on ENOV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERRY PHILLIP BENJAMIN BEN | Chief Financial Officer | Stock Award(Grant) | Mar 8, 2026 | 158,596 |
| ENGERT OLIVER | Officer | Purchase | Sep 3, 2026 | 63,898 |
| LANG PATRICIA A | Officer | Stock Award(Grant) | Mar 8, 2026 | 75,703 |
| MCDONALD DAMIEN | Chief Executive Officer | Purchase | Sep 3, 2026 | 247,077 |
| PRYOR DANIEL ALEXIS | Former | Sale | Dec 8, 2025 | 0 |
| ROSS TERRY D | Officer | Stock Award(Grant) | Mar 8, 2026 | 68,477 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 17.85% | 10,295,666 | 205.91M | Jun 29, 2026 |
| American Century Companies Inc | 10.59% | 6,106,561 | 122.13M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.81% | 3,926,268 | 78.53M | Jun 29, 2026 |
| Rubric Capital Management LP | 6.76% | 3,900,000 | 78.00M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.31% | 2,484,318 | 49.69M | Jun 29, 2026 |
| State Street Corporation | 4.27% | 2,462,788 | 49.26M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 3,431,569 | 68.63M | Sep 29, 2026 |
| American Century Capital Portfolios, Inc.-Small Cap Value Fund | 4.54% | 2,620,000 | 52.40M | Jun 29, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Value Fund | 4.04% | 2,328,360 | 46.57M | Jul 30, 2026 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 3.80% | 2,189,182 | 43.78M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.98% | 1,719,530 | 34.39M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.59% | 1,493,643 | 29.87M | Sep 29, 2026 |